Delayed diagnosis in non-insulin dependent diabetes mellitus.

onychomycosis. Clin Exp Dermatol 1987;12:175-7. 8 Petranyi G, Ryder NS,-Stutz A. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 1984;224: 1239-41. 9 Stutz A. Synthesis and structure-activity correlations within allylamine antimycotics. Ann N Y Acad Sci 1988;544:46-62. 10 Van de Bossche H, Willemsens G, Cools W, Lauwers WFJ, Lejeune L. Biochemical effects of miconazole on fungi. Inhibition of ergosterol biosynthesis in Candida albicans. Chemical and Biological Interactio(s 1978;21:59-78. 11 Back DJ, Stevenson P, TFia JF. Comparatise effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro. BrJ Clin Pharmacol 1989;28:166-70. 12 Savin R. Successful treatment of chronic tinea pedis (mocassin type) with terbinafine (Lamisil). Clin Exp Dermatol 1989;14:116-9. 13 Villars V, Jones TC. Present status of the efficacy and tolerability of terhinafine (Lamisil) used systemically in the treatment of dermatomvcoses of skin and nails. journal of Dermatological Treatment 1990;1(suppl 2):33-9. 14 Goodfield MJD, Rowell NR, Forster RA, Evans EGV, Raven A. Treatment of dermatophyte infection of the finger and toenails with terbinafine (SF 86-327, Lamisil), an orally active fungicidal agent. Br J Dermatol 1989;121:753-7. 15 Zaias N, Serrano L. rhe successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine. Clin Exp Dermatol 1989;14: 120-3. 16 Zaias N, Drackman DA. A method for the determination of drug effectiveness in onychomycosis. J7Am Acad Dermatol 1983;9:912-9. 17 Harland CC, Goodfield MJD, Evans EGV. A follow up study of terbinafine (SF-327, Lamisil) in the treatment of onychomycosis. Br 7 Dermatol 1990;123(suppl 37):31.